TRISOMY-12 AND K-RAS-2 AMPLIFICATION IN HUMAN OVARIAN-TUMORS

被引：36
|
作者：
YANGFENG, TL
LI, SB
LEUNG, WY
CARCANGIU, ML
SCHWARTZ, PE
机构：
[1] NATL YANG MING MED COLL,VET GEN HOSP,DEPT OBSTET & GYNECOL,TAIPEI,TAIWAN
[2] YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT OBSTET & GYNECOL,NEW HAVEN,CT 06510
来源：
INTERNATIONAL JOURNAL OF CANCER | 1991年 / 48卷 / 05期
关键词：
D O I：
10.1002/ijc.2910480508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cytogenetic analysis was performed on 11 benign and borderline ovarian tumors. Trisomy 12, identified as a sole abnormality in 6 tumors, is likely a specific karyotypic change in different benign and borderline tumors and may well be a primary chromosomal lesion in these tumors. The possible association between amplification of the proto-oncogene K-ras-2 which is located on chromosome 12 and trisomy 12 was investigated. DNA blotting analysis of 64 tumors indicates that trisomy 12 does not seem to be related to K-ras-2 amplification in ovarian tumors. K-ras-2 amplification was observed in 3 high-grade tumors from 3 patients with metastases.
引用
收藏
页码：678 / 681
页数：4
相关论文
共 50 条
  • [1] TRISOMY-12 IS A CONSISTENT CHROMOSOMAL ABERRATION IN BENIGN OVARIAN-TUMORS
    PEJOVIC, T
    HEIM, S
    MANDAHL, N
    ELMFORS, B
    FLODERUS, UM
    FURGYIK, S
    HELM, G
    WILLEN, H
    MITELMAN, F
    GENES CHROMOSOMES & CANCER, 1990, 2 (01): : 48 - 52
  • [2] FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS OF TRISOMY-12 IN OVARIAN-TUMORS
    PERSONS, DL
    HARTMANN, LC
    HERATH, JF
    KEENEY, GL
    JENKINS, RB
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (06) : 775 - 779
  • [3] TRISOMY-12 DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN OVARIAN-TUMORS
    PERSONS, DL
    HARTMANN, LC
    KEENEY, GL
    JENKINS, RB
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 341 - 341
  • [4] AMPLIFICATION OF C-RAS-KI ONCOGENE IN HUMAN OVARIAN-TUMORS
    BOLTZ, EM
    KEFFORD, RF
    LEARY, JA
    HOUGHTON, CR
    FRIEDLANDER, ML
    INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (03) : 428 - 430
  • [5] OVARIAN GRANULOSA STROMAL CELL TUMORS ARE CHARACTERIZED BY TRISOMY-12
    FLETCHER, JA
    GIBAS, Z
    DONOVAN, K
    PEREZATAYDE, A
    GENEST, D
    MORTON, CC
    LAGE, JM
    AMERICAN JOURNAL OF PATHOLOGY, 1991, 138 (03): : 515 - 520
  • [6] INTERPHASE CYTOGENETIC ANALYSIS FOR TRISOMY-12 IN OVARIAN SEX CORD-STROMAL TUMORS
    SHASHI, V
    GOLDEN, WL
    VONKAPHERR, C
    GAFFEY, MJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 364 - 364
  • [7] MUTATION OF K-RAS PROTOONCOGENE IS ASSOCIATED WITH HISTOLOGICAL SUBTYPES IN HUMAN MUCINOUS OVARIAN-TUMORS
    ICHIKAWA, Y
    NISHIDA, M
    SUZUKI, H
    YOSHIDA, S
    TSUNODA, H
    KUBO, T
    UCHIDA, K
    MIWA, M
    CANCER RESEARCH, 1994, 54 (01) : 33 - 35
  • [8] CLUSTER OF TRISOMY-12 TO TUMORS OF THE FEMALE GENITOURINARY TRACT
    KIECHLESCHWARZ, M
    PFLEIDERER, A
    SREEKANTAIAH, C
    BERGER, CS
    MEDCHILL, MT
    SANDBERG, AA
    CANCER GENETICS AND CYTOGENETICS, 1991, 54 (02) : 273 - 275
  • [9] CLASSIFICATION OF HUMAN OVARIAN-TUMORS
    SCULLY, RE
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1987, 73 : 15 - 24
  • [10] DETECTION OF TRISOMY-12 ON OVARIAN SEX CORD-STROMAL TUMORS BY FLUORESCENCE IN-SITU HYBRIDIZATION
    TARUSCIO, D
    CARCANGIU, ML
    WARD, DC
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1993, 2 (02) : 94 - 98
12345